Related content

The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy

By Georgoulopoulou Eleni   Fini Nicola   Vinceti Marco   Monelli Marco   Vacondio Paolo   Bianconi Giorgia   Sola Patrizia   Nichelli Paolo   Mandrioli Jessica  

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 14, Iss. 5-6, 2013-09 ,pp. : 338-345

Informa Healthcare

Access to resources Recommend Favorite

Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat

By Speiser Z.   Mayk A.   Litinetsky L.   Fine T.   Nyska A.   Blaugrund E.   Cohen S.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 595-605

Springer Publishing Company

Access to resources Recommend Favorite

Reduced GABAergic Inhibition Explains Cortical Hyperexcitability in the Wobbler Mouse Model of ALS

By Nieto-Gonzalez Jose Luis   Moser Jakob   Lauritzen Martin   Schmitt-John Thomas   Jensen Kimmo  

Cerebral Cortex, Vol. 21, Iss. 3, 2011-03 ,pp. : 625-635

Oxford University Press

Access to resources Recommend Favorite

Optimal methods to characterize the G93A mouse model of ALS

By Miana-Mena Francisco   Muñoz Maria   Yagüe Gema   Mendez Mario   Moreno Maria   Ciriza Jesús   Zaragoza Pilar   Osta Rosario  

Amyotrophic Lateral Sclerosis, Vol. 6, Iss. 1, 2005-03 ,pp. : 55-62

Informa Healthcare

Access to resources Recommend Favorite

Instrumental Activation of Bid by Caspase-1 in a Transgenic Mouse Model of ALS

By Guégan C.   Vila M.   Teissman P.   Chen C.   Onténiente B.   Li M.   Friedlander R.M.   Przedborski S.  

Molecular and Cellular Neuroscience, Vol. 20, Iss. 4, 2002-08 ,pp. : 553-562

Academic Press

Access to resources Recommend Favorite